Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$200M |
| 2 |
Danaher
DHR
|
+$146M |
| 3 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$138M |
| 4 |
Procter & Gamble
PG
|
+$122M |
| 5 |
RDS.B
Royal Dutch Shell PLC ADS Class B
RDS.B
|
+$109M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.89B |
| 2 |
Microsoft
MSFT
|
+$380M |
| 3 |
Alibaba
BABA
|
+$352M |
| 4 |
Wells Fargo
WFC
|
+$245M |
| 5 |
American Electric Power
AEP
|
+$243M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 11.41% |
| 2 | Technology | 7.27% |
| 3 | Financials | 6.46% |
| 4 | Consumer Discretionary | 5.3% |
| 5 | Industrials | 4.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HALL
3476
DELISTED
Hallmark Financial Services, Inc.
HALL
| $119K | ﹤0.01% |
2,946
-2,372
| -45% | -$321K |
|
|
PHK
3477
PIMCO High Income Fund
PHK
$873M
| $118K | ﹤0.01% |
24,170
-85,356
| -78% | -$581K |
|
|
ATNX
3478
DELISTED
Athenex, Inc. Common Stock
ATNX
| $118K | ﹤0.01% |
764
-38,415
| -98% | -$9.67M |
|
3479
Chemours
CC
$2.57B
| $116K | ﹤0.01% |
13,122
-25,283
| -66% | -$365K |
|
3480
CALL
Goodyear
GT
$2.02B
| $116K | ﹤0.01% |
+20,000
| New | +$218K |
|
|
VRS
3481
DELISTED
Verso Corporation
VRS
| $116K | ﹤0.01% |
+10,267
| New | +$160K |
|
3482
Amkor Technology
AMKR
$13.9B
| $115K | ﹤0.01% |
14,717
-614,206
| -98% | -$6.68M |
|
3483
BCB Bancorp
BCBP
$170M
| $115K | ﹤0.01% |
+10,815
| New | +$133K |
|
|
GREK
3484
Global X MSCI Greece ETF
GREK
$320M
| $115K | ﹤0.01% |
6,710
-32,608
| -83% | -$806K |
|
3485
Ultralife
ULBI
$87.4M
| $115K | ﹤0.01% |
22,129
+4,917
| +29% | +$33.6K |
|
|
BXRX
3486
DELISTED
Baudax Bio, Inc. Common Stock
BXRX
| $115K | ﹤0.01% |
33
-79
| -71% | -$746K |
|
|
WPX
3487
DELISTED
WPX Energy, Inc.
WPX
| $115K | ﹤0.01% |
37,681
-9,383,392
| -100% | -$88.5M |
|
3488
Fennec Pharmaceuticals
FENC
$333M
| $114K | ﹤0.01% |
+19,180
| New | +$125K |
|
3489
Revolve Group
RVLV
$1.86B
| $114K | ﹤0.01% |
+13,151
| New | +$209K |
|
3490
Spero Therapeutics
SPRO
$66.6M
| $114K | ﹤0.01% |
14,055
+1,373
| +11% | +$12.1K |
|
3491
PUT
Freeport-McMoran
FCX
$96.7B
| $113K | ﹤0.01% |
+16,800
| New | +$176K |
|
|
GSV
3492
DELISTED
Gold Standard Ventures Corp.
GSV
| $113K | ﹤0.01% |
225,918
+60,508
| +37% | +$40.1K |
|
3493
CarParts.com
PRTS
$44.2M
| $111K | ﹤0.01% |
+6,358
| New | +$154K |
|
|
RYZ
3494
Ryerson Holding Corp
RYZ
$1.46B
| $111K | ﹤0.01% |
20,933
-114,515
| -85% | -$1.01M |
|
|
BCOW
3495
DELISTED
1895 Bancorp of Wisconsin
BCOW
| $109K | ﹤0.01% |
18,325
+255
| +1% | +$2.01K |
|
|
SLCT
3496
DELISTED
Select Bancorp, Inc.
SLCT
| $108K | ﹤0.01% |
14,162
-37,345
| -73% | -$393K |
|
|
UNT
3497
DELISTED
UNIT Corporation
UNT
| $106K | ﹤0.01% |
406,567
-1,544,652
| -79% | -$584K |
|
3498
APA Corp
APA
$13B
| $105K | ﹤0.01% |
25,025
-456,696
| -95% | -$10.2M |
|
3499
Genprex
GNPX
$2.4M
| $105K | ﹤0.01% |
+1
| New | +$103K |
|
3500
BioCardia
BCDA
$12.4M
| $104K | ﹤0.01% |
2,145
-2
| -0.1% | -$124 |
|
Similar funds
Millennium Management's Q1 2020 Portfolio in Review
As of Q1 2020, Millennium Management held 4,928 positions worth $44.5B, down 44% from $79.9B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Millennium Management withdrew a net $21.4B in Q1 2020, closing 1,154 positions and reducing 1,745 holdings. Its most notable exit was Becton Dickinson, an estimated $152M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 11% of assets, up from 9.7% a quarter earlier, followed by Technology and Financials.
Against the trend, Millennium Management opened a new position in Danaher worth $133M.
- Millennium Management's largest Q1 2020 buy was Danaher: 1,082,448 shares worth $133M.
- Millennium Management added most to Allergan plc in Q1 2020, an estimated $200M increase.
- Millennium Management's biggest Q1 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $3.89B.
- Millennium Management fully exited Becton Dickinson in Q1 2020, selling an estimated $152M.
- Millennium Management's ten largest holdings make up 18% of its $44.5B portfolio in Q1 2020.
- Millennium Management opened 789 new positions and closed 1,154 in Q1 2020.
- Millennium Management's portfolio value fell 44% quarter-over-quarter to $44.5B.
Based on Millennium Management's 13F filing for Q1 2020, filed 14 May 2020.